Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 197,673 | 85,777 | 49,868 | 17,806 | -28,239 |
| Depreciation Amortization | 8,853 | 6,726 | 4,570 | 2,331 | 10,783 |
| Income taxes - deferred | -84,280 | N/A | N/A | 0 | N/A |
| Accounts receivable | -22,578 | -22,719 | -2,692 | -22,200 | -11,916 |
| Accounts payable and accrued liabilities | 4,150 | 208 | -1,410 | 447 | 3,839 |
| Other Working Capital | -18,539 | -32,262 | -16,038 | -24,519 | -10,123 |
| Other Operating Activity | 33,393 | 30,726 | 9,130 | 23,917 | 44,456 |
| Operating Cash Flow | $118,672 | $68,456 | $43,428 | $-2,218 | $8,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,226 | -5,469 | -4,413 | -2,347 | -4,771 |
| Purchase Sale Intangibles | -349 | -356 | -314 | -15 | -210 |
| Other Investing Activity | -349 | -356 | -314 | -15 | -210 |
| Investing Cash Flow | $-8,575 | $-5,825 | $-4,727 | $-2,362 | $-4,981 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -30,000 | N/A | N/A | 135,000 |
| Debt Repayment | -60,825 | N/A | N/A | N/A | -171,327 |
| Common Stock Issued | 7,494 | 7,051 | 1,360 | 1,029 | 1,104 |
| Other Financing Activity | -4,971 | -4,327 | -3,169 | -2,476 | -3,766 |
| Financing Cash Flow | $-58,302 | $-27,276 | $-1,809 | $-1,447 | $-38,989 |
| Beginning Cash Position | 51,352 | 51,352 | 51,352 | 51,352 | 86,522 |
| End Cash Position | 103,147 | 86,707 | 88,244 | 45,325 | 51,352 |
| Net Cash Flow | $51,795 | $35,355 | $36,892 | $-6,027 | $-35,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | 118,672 | 68,456 | 43,428 | -2,218 | 8,800 |
| Capital Expenditure | -8,226 | -5,469 | -4,413 | -2,347 | -4,771 |
| Free Cash Flow | 110,446 | 62,987 | 39,015 | -4,565 | 4,029 |